Understanding of the importance of this role ultimately led to the discovery that tumors utilize critical immune checkpoint molecules such as programmed death ligand 1 (PD-L1) and cytotoxic T lymphocyte associated protein 4 (CTLA-4) as a means to prevent immune activation towards cancer cells (35, 36). Here, CTLA4 is linked to cancer.